Table of Content - Volume 5 Issue 1 - January 2017
Clinical profile of hypertrophic Cardiomyopathy
Rajshekhar I Koujalgi
Associate Professor, Department of Medicine, Bidar Institute of Medical Sciences, Bidar, Karnataka, INDIA. Email: rajshekharik@gmail.com
Abstract Background: Hypertrophic cardiomyopathy (HCM) is defined by increased left ventricular (LV) wall thickness (R15 mm in one or more LV myocardial segments), that cannot be explained by abnormal loading conditions. The clinical spectrum of HCM is complex and includes a variety of phenotypes, which leads to different types of manifestations. Although most of the patients are asymptomatic, up to 25% will develop symptoms or risk of arrhythmias and sudden cardiac death (SCD). Aims and Objectives: To study the clinical profile of patients of Hypertrophic Cardiomyopathy reporting to a tertiary care centre situated in north Karnataka catering largely to a rural population. Material and Methods: The present study was conducted in the Department of Medicine of Bidar Institute of Medical Sciences., Bidar. For the purpose of study total 105 cases of Hypertrophic Cardiomyopathy reporting to the department of Medicine were selected. The diagnosis of HCM was based on 2D Echocardiographic (2D Echo) and ECG documentation. The cases include newly diagnosed and known cases also. After receiving approval from institutional ethical committee, the study was conducted. Informed written consent from all the selected study patients was obtained.Detail history of each patient was recorded on a prestructured proforma. Details regarding age, sex, address and socioeconomic status were noted. Information regarding the presenting complaints, any significant past and family history was also recorded. Complete general and systemic examination was performed in all the patients and the findings were recorded. Results: Mean age of patients was 49.79± 14.66years. Majority (73.33%) of the patients were male. The most common presenting complaint was angina followed by dyspnea on exertion. Past history of hypertrophic cardiomyopathy was reported by 41.90% patients. Family history of hypertrophic cardiomyopathy was observed in 9.52%. Prominent JVP ‘a’ wave was noted in 23.81% patients in the study.S3 heart sound was heard in 6.67% patients where as S4 was heard in 79.05% patients. Left ventricular outflow tract murmur was present in 54.29% patients and mitral regurgitation was observed in 17.14% patients of HCM. On 2D Echo inter ventricular septum thickness and posterior wall thickness in diastole was significantly more in apical HCM as compared to other HCM variants. Left atrium size was also significantly increased in HOCM (38.60±7.94). Mean left ventricular diastolic dysfunction was observed in higher grades in HCM andapical HCM as compared to HOCM and the difference observed was also statistically significant. The mean left ventricular ejection fraction was lowest in HCM and was statistically significant as compared to apical HCM and HOCM. Conclusion: Hypertrophic obstructive cardiomyopathy (HOCM) was the commonest cardiomyopathy in the present study. Cardiomyopathy presented with wide variation in clinical features with angina and dyspnea on exertion as the most common presenting complaint. Prominent ‘a’ wave of JVP and audible fourth heart sound with Left ventricular outflow tract murmur are the common clinical features associated with HCM. 2D Echo examination in HCM was the most important investigation for diagnosis and also for cardiac functional assessment. Key Words: Hypertrophic Cardiomyopathy, angina, dyspnea, LVOT murmur.
INTRODUCTION Although the pathology of HCM was described by two French pathologists in the mid 19th century1,2 and by a German pathologist in the early 20th century,3 it remained for the virtually simultaneous reports of Brock et al4 and Teare et al5, some 37 years ago, to bring modern attention to this fascinating entity. Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease and the leading cause of sudden cardiac death in the young and is also associated with heart failure, disability, and death at any age.6,7,8Hypertrophic cardiomyopathy (HCM) is defined by increased left ventricular (LV) wall thickness (R15 mm in one or more LV myocardial segments), that cannot be explained by abnormal loading conditions9.The clinical spectrum of HCMis complex and includes a variety of phenotypes, which leads to different types of manifestations. Although most of the patients are asymptomatic, up to 25% will develop symptoms or risk of arrhythmias and sudden cardiac death (SCD) 10.
MATERIAL AND METHODS The present study was conducted in the Department of Medicine of Bidar Institute of Medical sciences., Bidar. For the purpose total 105 cases of Hypertrophic Cardiomyopathy reporting to the department of medicine were selected. The diagnosis of HCM was based on 2D echocardiographic and ECG documentation. Patient selection Inclusion criteria Adults: In an adult, HCM defined by a wall thickness ≥15 mm in one or more LV myocardial segments—as measured by imaging technique echocardiography., that is not explained solely by loading conditions. Children: An LV wall thickness more than two standard deviations greater than the predicted mean (z-score. 2, where a z-score is defined as the number of standard deviations from the population mean). Exclusion Criteria
The cases include newly diagnosed and known cases also. After receiving approval from institutional ethical committee, the study was conducted. Informed written consent from all the selected study patients was obtained. Detail history of each patient was recorded on a prestructured proforma. Details regarding age, sex, address and socioeconomic status were noted. Information regarding the presenting complaints, any significant past and family history was also recorded. Complete general and systemic examination was performed in all the patients and the findings were recorded.
RESULTS
Table 1: Distribution according to type of cardiomyopathy
In the present study of Hypertrophic cardiomyopathy, a total number of 105 patients satisfied the inclusion criteria. It was observed that hypertrophic obstructive cardiomyopathy (64.76%) was the most common type observed in the present study.
Table 2: Age distribution of patients
* Statistically significant difference between HCM apical and HCM, # Statistically significant difference between HCM apical and HOCM, $ Statistically significant difference between HCM and HOCM It was seen that age group of patients ranged from a minimum of 8 years to a maximum of 72 years. The mean age of patients of HOCM was 48.28±14.457 years, similarly in HCM with diffuse hypertrophy was 49.2±15.335 years, however Apical HCM had higher age group of 60.82±10.916 years. Table 3: Sex distribution of patients
It was observed that, out of 105 patients 77 (73.3%) were male with mean age of 49.0±15.303 years and 28 (26.7%) were female with slightly higher mean age of 51.96±12.732 years. But the difference in sexwise age distribution not statistically significant. Table 4: Distribution of patients according to presenting complaints
Figure 1: Distribution of patients according to presenting complaints The most common presenting complaint was angina followed by dyspnea on exertion. Palpitation and Syncope was reported by 18.10% and 14.29% patientsrespectively. Only 1 patient had resuscitated cardiac arrest and one patient was asymptomatic. Most of the patients with Angina, Dyspnea, Palpitations had NYHA class II severity.
Table 5: Distribution of patients according to past and familyhistory
Past history of hypertrophic cardiomyopathy was reported by 41.90% patients. 21.90% patients were known hypertensive whereas 15.24% were diabetic in the present study. Knowncases of arrhythmia were 9.52% patients.Family history of hypertrophic cardiomyopathy was observed in 9.52% whereas history of sudden cardiac death in family was given by 5.71% patients. Table 6: Distribution of patients according to examination findings
The mean pulse rate in the study patients was 84.83± 17.85 per min. Systolic blood pressure(SBP) was 124.71 ± 19.01 mm of Hg whereas Diastolic blood pressure(DBP) was 78.37 ± 8.67 mm of Hg. Prominent JVP‘a’ wave was noted in 23.81% patients in the study. S3 heart sound was heard in 6.67% patients where as S4 was heard in 79.05% patients.Left ventricular outflow tract murmur was present in 54.29% patients and mitral regurgitation was observed in 17.14% patients of HCM.
Table 7: Distribution of various ECHO findings in cardiomyopathy patients
*Statistically significant difference between HCM apical and HCM, # Statistically significant difference between HCM apical and HOCM, $ Statistically significant difference between HCM and HOCM
On 2D Echo inter ventricular septum thickness and posterior wall thickness in diastole was significantly more in apical HCM as compared to HCM. Left atrium size was also significantly increased in HOCM (38.60±7.94). Mean left ventricular diastolic dysfunction was observed in higher grades in HCM and apical HCM as compared to HOCM and the difference observed was also statistically significant. The mean left ventricular ejection fraction was lowest in HCM and was statistically significant as compared to apical HCM and HOCM.
DISCUSSION The present study was conducted in the Department of Medicine of Bidar Institute of Medical Sciences., Bidar. For the purpose of study total 105 cases of hypertrophic cardiomyopathy were selected. The cases include new as well as old cases. In the present study patients ranged from 8 years to 72 years of age. Mean age of patients was 49.79±14.66years. Majority (73.33%) of the patients were male and were belonging to lower socioeconomic class.The most common presenting complaint was angina (66.67%) followed by dyspnea (62.86%) on exertion. Palpitation and syncope was reported by 18.10% and 14.29% patients respectively. According to Braunwald E et al6, Wigle ED et al8 and Maron BJ et al11patients with obstructive HCM typically complain of dyspnea, angina, and presyncope and/or syncope on exertion. The severity of symptoms on upright exertion does not necessarily correlate with the magnitude of the obstructive pressure gradient measured in the supine position, which is understandable, particularly when the lability of the obstruction is taken into account. Patients with nonobstructive HCM present with these symptoms less frequently, and usually the symptoms are milder.12The clinical course of HCM is variable. Many patients are asymptomatic or mildly symptomatic. The symptoms of HCM include dyspnea due to stiffening and decreased blood filling of the ventricles, angina i.e. exertional chest pain due to reduced or restricted blood flow to the coronary arteries, palpitations due to the aforementioned ischemia, as well as disruption of the electrical system running through the abnormal heart muscle, light headedness, fatigue, fainting or syncope and sudden cardiac death. As mentioned, dyspnea is largely due to increased stiffness of the left ventricle, which impairs filling of the ventricles, but also leads to elevated diastolic pressure in the left ventricle and left atrium, causing back pressure and interstitial congestion in the lungs. Symptoms are not closely related to the presence or severity of an outflow tract gradient.13According to Elliott PMet al14 although presyncope and syncope on exertion are common in obstructive HCM, it is extremely important to recognise that these symptoms may also result from atrial and ventricular arrhythmias at rest or on exertion, or from failure of blood pressure to rise normally on exertion, even in non-obstructive HCM. Thus, a history of palpitations, particularly rapid heart action when associated with presyncope/syncope, is an integral part of history taking.Family history of hypertrophic cardiomyopathy was observed in 9.52% whereas history of sudden cardiac death in family was given by 5.71% patients.Recently, the results of molecular genetic studies have resulted in a quantum leap in our basic knowledge and understanding of the mendelian dominant inheritance of HCM and have far-reaching prognostic and clinical implications.15,16,17 HCM is now described as a heterogeneous disease of the sarcomere,15,18 in that at least 34 missense mutations have been described in the β-myosin heavy chain gene (chromosome 14q11-q12)19,20, 7 mutations have been described in cardiac troponin-T (chromosome 1),18 and 2 mutations in α-tropomyosin (chromosome 15q2).15,18 Another locus has been found on chromosome 11p13-q13,21 and familial HCM with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.17 The hypertrophy in HCM may be compensatory in response to the abnormalities induced by these mutations. This belief is supported by the upregulation of genes commonly observed in compensatory hypertrophy, ie, atrial and brain natriuretic peptides and angiotensin-converting enzyme.22,23 These molecular genetic studies are already having important clinical implications in that some mutations carry a benign prognosis,18 whereas others, possibly interacting with angiotensin-converting enzyme genotypes,24 have increased penetrance, early onset of manifestations, and a bad prognosis,18,25 thus explaining the malignant family history noted by some authors.12,26The mean pulse rate in the study patients was 84.83± 17.85 per min. systolic blood pressure was 124.71 ± 19.01 mm of Hg whereas diastolic blood pressure was 78.37 ± 8.67 mm of Hg. Prominent JVP‘a’ wave was noted in 23.81% patients in the study. Fourth heart sound was heard in 79.05% patients. Left ventricular outflow tract murmur was present in 54.29% patients and mitral regurgitation was observed in 17.14% patients of HCM. Prominent ‘a’ wave in the jugular venous pulse indicates RV involvement in HCMmay be detected by and rarely by a right-sided fourth heart sound, reflecting RV diastolic dysfunction, and by a systolic ejection murmur along the left sternal border, reflecting subpulmonic or midventricular obstruction to RV outflow.8,27On 2D Echo interventricular septum thickness and posterior wall thickness in diastole was significantly more in apical HCM as compared to HCM.Left atrium size was also significantly increased in HOCM (38.60±7.94). Mean left ventricular diastolic dysfunction was observed in higher grades in HCM and apical HCM as compared to HOCM and the difference observed was also statistically significant. The mean left ventricular ejection fraction was lowest in HCM and was statistically significant as compared to apical HCM and HOCM.Transthoracic Echo/Doppler examination in HCM is undoubtedly the most important form of laboratory investigation. These combined techniques can determine the location and extent of hypertrophy, systolicand diastolic function, the presence and degree of systolic anterior motion of mitral valve, the severity of the subaortic and/or midventricular obstruction, the direction and degree of mitral regurgitation, the presence of additional mitral valve abnormalities and LA size. Transesophageal echo/Doppler studies are valuable in defining additional mitral valve abnormalities and the level of outflow obstruction and are used intraoperatively in planning, guiding, and assessing the results of surgical intervention.28-31
CONCLUSION Thus from the above results and discussion we conclude thatHypertrophic obstructive cardiomyopathy was the commonest cardiomyopathy in the present study. Hypertrophic Cardiomyopathy presented with wide variation in clinical features with angina and dyspnea on exertion as the most common presenting complaint. Prominent ‘a’ wave of JVP and audible fourth heart sound with Left ventricular outflow tract murmur are the common clinical features associated with HCM. 2 D echo examination in HCM was the most important investigation for diagnosis and also for cardiac functional assessment.
REFERENCES
Policy for Articles with Open Access
|
|